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With the advent of whole genome sequencing made
clinically available, the number of incidental findings is
likely to rise. False positive incidental findings are of
particular clinical concern, and they can usefully be clas-
sified into four categories. In order of increasing chal-
lenge, there is first, the substantial proportion of
‘textbook cases’ of mutations documented to cause
human disease in a highly penetrant Mendelian fashion,
which are incorrectly annotated in the databases. The
second is the technical/measurement error rate in gen-
ome-scale sequencing. Third is the incorrect assignment
of prior probabilities for much of our genetic and geno-
mic knowledge. The fourth derives from testing multiple
hypotheses across millions of variants. I will describe the
nature of these components, provide rough estimates for
the magnitude of the problem and point out existing
approaches that will serve to control the growth of these
aspects of the incidentalome.
Published: 1 October 2012
doi:10.1186/1753-6561-6-S6-O13
Cite this article as: Kohane: How to avoid one thousand opportunities
to do harm in genomic medicine. BMC Proceedings 2012 6(Suppl 6):O13.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Children’s Hospital Boston, MA, USA
Kohane BMC Proceedings 2012, 6(Suppl 6):O13
http://www.biomedcentral.com/1753-6561/6/S6/O13
© 2012 Kohane; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
